Alberta Investment Management Corp (AIMCo)’s Moderna MRNA Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48,000	Closed	-$1.42M	–	768
2025 Q4	$1.42M	Buy	+48,000	New	+$1.3M	0.01%	548
2025 Q2	–	Sell	-74,290	Closed	-$2.11M	–	777
2025 Q1	$2.11M	Hold	74,290	–	–	0.01%	450
2024 Q4	$3.09M	Sell	74,290 -5,196	-7%	-$248K	0.02%	380
2024 Q3	$5.31M	Hold	79,486	–	–	0.05%	224
2024 Q2	$9.44M	Sell	79,486 -11,939	-13%	-$1.51M	0.1%	155
2024 Q1	$9.74M	Sell	91,425 -6,300	-6%	-$635K	0.1%	165
2023 Q4	$9.72M	Buy	97,725 +9,900	+11%	+$833K	0.09%	148
2023 Q3	$9.07M	Hold	87,825	–	–	0.1%	197
2023 Q2	$10.7M	Hold	87,825	–	–	0.1%	192
2023 Q1	$13.5M	Buy	87,825 +15,904	+22%	+$2.62M	0.13%	163
2022 Q4	$12.9M	Hold	71,921	–	–	0.11%	197
2022 Q3	$8.51M	Hold	71,921	–	–	0.07%	319
2022 Q2	$10.3M	Sell	71,921 -68,000	-49%	-$9.72M	0.07%	281
2022 Q1	$24.1M	Buy	139,921 +48,685	+53%	+$8.2M	0.14%	154
2021 Q4	$23.2M	Buy	91,236 +77,236	+552%	+$22.6M	0.14%	153
2021 Q3	$5.39M	Sell	14,000 -7,014	-33%	-$2.59M	0.05%	407
2021 Q2	$4.94M	Buy	+21,014	New	+$3.76M	0.04%	435

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s MRNA Position: Q1 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Moderna (MRNA) in Q1 2026, closing a stake of 48,000 shares — an estimated $1.42M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in MRNA in Q2 2021 and held it in 17 quarters. The position peaked at $24.1M in Q1 2022. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Alberta Investment Management Corp (AIMCo) reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 48,000 Moderna shares in Q1 2026, an estimated $1.42M.
Alberta Investment Management Corp (AIMCo) first reported a position in Moderna in Q2 2021 and held it in 17 quarters.
Alberta Investment Management Corp (AIMCo)'s Moderna position peaked at $24.1M in Q1 2022.
726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.